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Manufacturing processes that produce biotherapeutic medicines rely heavily on chemical engineering principles 
alongside deep biological understanding. With the invent of high-speed, high-throughput data acquisition 
capability of recent years, there is a need for high-speed data analytics and visualization to get the most value 
out of the data. Yet, most processing is still done in user-specific spreadsheets with highly time-consuming, 
manual inputs and calculations. Further, when challenges arise, it becomes necessary to couple reams of 
disparate data sources, often in multiple iterations, to better understand the complex bioreactor or purification 
dynamics. It is not uncommon for a technical team to need to leverage significant historical data to enable small-
scale model verification and provide insights into various scale-up challenges, all within a very tight product 
development timeline. This old-fashioned way of handling data is especially problematic due to the rapidly 
increasing number of cell therapies that need to be transitioned from a proof-of-concept phase to a scale and 
quality suitable for commercial production, with even more limited resources and time. The right data, including 
a way to assess it quickly and easily in collaboration with colleagues, is needed to understand the potential 
effect that process scaling may have on product comparability. Since this session focuses on process scale-up 
and characterization, this presentation will focus on how to implement a data analytics strategy that can put a 
more holistic “molecule development view" right at our fingertips. The approach, using industrially-relevant case 
studies, will highlight how to better assess all of the data gathered in order to more rapidly advance promising 
molecules, while using fewer resources and ultimately seeing new patterns and relationships that otherwise 
would have remained unknown. In this presentation, we will focus on case studies that illustrate how scientists 
rapidly achieved these specific improvements: 1) uncovered important issues related to bioreactor scale up, 
including rapid comparisons of key process steps across multiple batches at the 3L, 100L and 1000L scale, 2) 
enabled rapid data analytics efforts to be able to dig deeper into the physics of a process and explore data in a 
new way for both upstream and downstream processes, 3) developed a methodology that provided a framework 
for comparing outcomes across upstream and downstream processes, all within the same application 
environment, and 4) facilitated inter-department collaboration during an investigation phase. By replacing the old 
time-consuming approaches typically used for analyzing data, there is more opportunity to develop quality 
insight into the key performance indicators, thus supporting a more holistic “molecule-development view” when 
scaling a process. Using a streamlined data analytics strategy enables the development of a truly robust 
understanding of the physical situation from early development through commercialization. 
 
 
Reference: Graham, L.J. (Alkemy Innovation, Inc.), and T. Barreira (Merrimack Pharmaceuticals, Inc.) 
"Leveraging a Data Strategy with Seeq to Create the Optimal Biotherapeutic Development Process," poster 
presentation at the Bioprocessing Summit Conference, Boston, MA, August 15-19. 
 
